LPTH vs REGN · rev $37.2M vs P/E 14, rev $14.34B
LightPath Technologies Inc (LPTH) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
LightPath Technologies Inc (LPTH) is a electronic components company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported LPTH revenue for 2025-06-30 was $37.2M. Net income was -$14.9M. Revenue was up 17.3% from 2024-06-30 to 2025-06-30. LPTH currently screens at market cap $980.8M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
LPTH currently screens at market cap $980.8M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the LPTH and REGN stock pages for the full models.
Not investment advice.